September 03, 2024 at 9:31 am

PRISM MarketView Launches Emerging Weight Loss Index

According to the World Health Organization (WHO), worldwide adult obesity has more than doubled since 1990, and adolescent obesity has quadrupled. In 2022, 1 in 8 people in the world or 890 million people were living with obesity while 2.5 billion were overweight. Originally designed to combat type 2 diabetes, drugs such as Novo Nordisk’s… [Read More]
August 30, 2024 at 4:04 pm

MongoDB’s Stock Gained Today -Here’s why

MongoDB (NASDAQ: MDB) shares are on the rise today, following the cloud software firm’s impressive Q2 earnings report which surpassed top and bottom-line estimates and increased its yearly guidance. As of 10:11 a.m. ET, the stock saw a 14% boost on the news.  MongoDB on the Rebound…Having suffered a drop after its Q1 earnings report,… [Read More]
August 30, 2024 at 3:24 pm

Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more

Midday Trading Headlines: Intel Intel shares rose by 8.5% as the company initiates collaboration with financial experts to strategize on improving its primary business operations. Elastic NV Shares plummeted by over 27% after the AI search enterprise’s Q2 financial forecast fell short of Wall Street’s projections. MongoDB The developer data platform enjoyed an approximate 16%… [Read More]
August 30, 2024 at 3:07 pm

PRISM Weight Loss Index Leader LEXX Soars 24% on Positive DehydraTECH-Processed Rybelsus® Study Results

Lexaria Bioscience Corp. (NASDAQ: LEXX), today’s standout in the PRISM Weight Loss Index, saw its shares surge 24% following the announcement of promising results from its second human pilot study, GLP-1-H24-2. The study highlighted the benefits of DehydraTECH-processed Rybelsus® capsules, designed to enhance the delivery of the GLP-1 drug semaglutide. Key Highlights: No Adverse Events:… [Read More]
August 29, 2024 at 3:07 pm

Stocks making the biggest moves midday: Dollar General, Affirm, Best Buy and more

Explore the businesses that are turning heads in the middle of the day’s trading. Dollar General’s shares took a major hit, plunging nearly 30% after the reduction in yearly sales and profit forecast. CEO Todd Vasos attributed diminished sales trends to financially distressed core customers. Their fiscal Q2 results also fell short, leading to a… [Read More]
August 29, 2024 at 11:13 am

NIH Funds $2.4 Million Psychedelic Research for Meth Addiction Treatment

The National Institutes of Health (NIH) is directing $2.4 million towards research on psychedelics to address methamphetamine use disorders. This funding responds to a sharp rise in deaths from methamphetamine, with fatal overdoses increasing nearly fivefold from 2015 to 2022. The grant recipients, including researchers from UCSD’s Center for Psychedelic Research, LSU Health Shreveport, and… [Read More]
August 29, 2024 at 10:50 am

OS Therapies Reaches Major Milestone in Osteosarcoma Phase 2b Clinical Trial

Company marches another step closer to delivering the first new treatment for osteosarcoma in 40 years OS Therapies (NYSE-A: OSTX), a leading biopharmaceutical company specializing in ADC and immunotherapy research, has announced a major milestone in its AOST-2121 clinical trial (NCT04974008) for OST-HER2. The trial, which targets recurred, resected osteosarcoma, has completed its final treatment… [Read More]